Literature DB >> 16157930

Thymus changes in anti-MuSK-positive and -negative myasthenia gravis.

E Saka, M A Topcuoglu, B Akkaya, A Galati, M Z Onal, A Vincent.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16157930     DOI: 10.1212/wnl.65.5.782

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  8 in total

Review 1.  Muscle-Specific Tyrosine Kinase and Myasthenia Gravis Owing to Other Antibodies.

Authors:  Michael H Rivner; Mamatha Pasnoor; Mazen M Dimachkie; Richard J Barohn; Lin Mei
Journal:  Neurol Clin       Date:  2018-05       Impact factor: 3.806

2.  Switch to double positive late onset MuSK myasthenia gravis following thymomectomy in paraneoplastic AChR antibody positive myasthenia gravis.

Authors:  Berit Jordan; Susanne Schilling; Stephan Zierz
Journal:  J Neurol       Date:  2015-12-08       Impact factor: 4.849

3.  Treatment of MuSK-Associated Myasthenia Gravis.

Authors:  Khalid El-Salem; Ahmed Yassin; Kefah Al-Hayk; Salma Yahya; Duha Al-Shorafat; Said S Dahbour
Journal:  Curr Treat Options Neurol       Date:  2014-04       Impact factor: 3.972

4.  Autoantibodies to agrin in myasthenia gravis patients.

Authors:  Bin Zhang; Chengyong Shen; Beverly Bealmear; Samia Ragheb; Wen-Cheng Xiong; Richard A Lewis; Robert P Lisak; Lin Mei
Journal:  PLoS One       Date:  2014-03-14       Impact factor: 3.240

Review 5.  Muscle-Specific Kinase Myasthenia Gravis.

Authors:  Lucia S Borges; David P Richman
Journal:  Front Immunol       Date:  2020-05-08       Impact factor: 7.561

6.  Myasthenia gravis: MuSK MG, late-onset MG and ocular MG.

Authors:  Feza Deymeer
Journal:  Acta Myol       Date:  2020-12-01

7.  Muscle-specific receptor tyrosine kinase antibody positive myasthenia gravis current status.

Authors:  Shin Joong Oh
Journal:  J Clin Neurol       Date:  2009-06-30       Impact factor: 3.077

Review 8.  Myasthenia gravis: a clinical-immunological update.

Authors:  Sophie Binks; Angela Vincent; Jacqueline Palace
Journal:  J Neurol       Date:  2015-12-24       Impact factor: 4.849

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.